Cardiac Conduction and Repolarization Completed Phase 1 Trials for Custirsen (DB05487)

IndicationStatusPhase
DBCOND0064230 (Cardiac Conduction and Repolarization)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01874561Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac RepolarizationTreatment